Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEVI STRAUSS & CO Director's Dealing 2023

Apr 21, 2023

30653_dirs_2023-04-21_7245c940-c295-4099-b379-f569a7c3f22f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: LEVI STRAUSS & CO (LEVI)
CIK: 0000094845
Period of Report: 2019-03-25

Reporting Person: Singh Harmit J (Executive VP and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-03-25 Common Stock J 6050 $0.00 Disposed 105930 Direct
2019-03-25 Common Stock J 105930 $0.00 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-03-25 Class B Common Stock $ J 6050 Acquired Class A Common Stock (6050) Direct
2019-03-25 Class B Common Stock $ J 105930 Acquired Class A Common Stock (105930) Direct
2019-03-25 Stock Appreciation Rights $6.10 J 976390 Disposed 2023-02-09 Common Stock (976390) Direct
2019-03-25 Stock Appreciation Rights $6.10 J 976390 Acquired 2023-02-09 Class B Common Stock (976390) Direct
2019-03-25 Stock Appreciation Rights $7.425 J 792450 Disposed 2022-02-04 Common Stock (792450) Direct
2019-03-25 Stock Appreciation Rights $7.425 J 792450 Acquired 2022-02-04 Class B Common Stock (792450) Direct
2019-03-25 Stock Appreciation Rights $6.45 J 660790 Disposed 2021-02-05 Common Stock (660790) Direct
2019-03-25 Stock Appreciation Rights $6.45 J 660790 Acquired 2021-02-05 Class B Common Stock (660790) Direct
2019-03-25 Stock Appreciation Rights $3.775 J 246210 Disposed 2020-02-05 Common Stock (246210) Direct
2019-03-25 Stock Appreciation Rights $3.775 J 246210 Acquired 2020-02-05 Class B Common Stock (246210) Direct
2019-03-25 Stock Appreciation Rights $14.875 J 89440 Disposed 2029-01-29 Common Stock (89440) Direct
2019-03-25 Stock Appreciation Rights $14.875 J 89440 Acquired 2029-01-29 Class B Common Stock (89440) Direct
2019-03-25 Stock Appreciation Rights $9.60 J 138670 Disposed 2025-01-30 Common Stock (138670) Direct
2019-03-25 Stock Appreciation Rights $9.60 J 138670 Acquired 2025-01-30 Class B Common Stock (138670) Direct
2019-03-25 Stock Appreciation Rights $6.90 J 216980 Disposed 2024-02-01 Common Stock (216980) Direct
2019-03-25 Stock Appreciation Rights $6.90 J 216980 Acquired 2024-02-01 Class B Common Stock (216980) Direct

Footnotes

F1: Immediately prior to the closing of the Issuer's initial public offering, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F2: This Form 4/A is being filed to correct the disclosure relating to RSUs set forth in the Form 4 filed on March 27, 2019 (the "Original Form 4"), which were inadvertently disclosed in Table I instead of Table II in the Original Form 4. As a result, certain subsequent instances of withholding of shares to satisfy tax liabilities were reported solely within Table I.

F3: Each share is represented by a restricted stock unit (RSU) that may be settled in shares of Class B Common Stock. Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement. Of these RSUs, (i) 50,720 RSUs vest on February 1, 2020, (ii) 28,320 RSUs vest in four equal annual installments beginning on January 30, 2019, and (iii) 26,890 RSUs vest in four equal annual installments beginning on January 30, 2020.

F4: Each stock appreciation right (SAR) represents the right to receive, upon exercise, shares of the Issuer's Common Stock (and, after the conversion noted in footnote (1), Class B Common Stock) with a value equal to the increase in the fair market value of one share of such stock from the date of grant of the SAR.

F5: Of these SARs: (i) 443,810 are performance stock appreciation rights (PSARs) that vested on January 30, 2019 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 532,580 SARs that vested as to 25% of the SARs on February 9, 2017, with the remainder vesting in 36 equal monthly installments thereafter.

F6: Of these SARs: (i) 337,020 are PSARs that vested on January 30, 2018 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 455,430 SARs that are fully vested.

F7: Of these SARs: (i) 220,270 are PSARs that vested on February 1, 2017 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors; and (ii) 440,520 SARs that are fully vested.

F8: These SARs are PSARs that vested on March 1, 2016 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors.

F9: 25% of the SARs vest on January 30, 2020, and 1/3 of the remaining SARs vest annually beginning on January 30, 2021.

F10: 25% of the SARs vested on January 30, 2019, and 1/3 of the remaining SARs vest annually beginning on January 30, 2020.

F11: 25% of the SARs vested on February 1, 2018, and 1/3 of the remaining SARs vest annually beginning on February 1, 2019.